A strategy is described for identifying structural changes in genetic variants of human serum albn (alloalbumins). By use of this strategy we have determined an amino acid'substitution in three alloalbumins of Asiatic origin.
both from families that migrated from northern India, and also in albumin' Adana from Turkey. This exchange corresponds to a single base mutation in the codon GAG to AAG and' accords with the slow mobility of the three albumins at pH 8.6 . Each of the three alloalbumins had been reported to be a new variant, yet they have'the same substitution. These results emphasize the need for structural study of genetic variants that have been differentiated only by nonspecific physical criteria such as'dye binding and electrophoretic mobility, We know of no other description of the substitution involved in an alloalbumin originating from the Indian subcontinent. However, the same change of glutamic acid-. lysine'at position 501 may be present in several other named variants reported for populations in north India and the'surrounding regions.
More than a decade ago about 100 genetic variants (allotypes) of human serum albumin bearing differing geographical or ethnic names had been reported on the basis of identification by clinical electrophoresis or by genetic screening with a series of electrophoretic methods (1, 2) , but few had been subjected to structural study until recently. Already, more variants are known for albumin than for any other protein except hemoglobin, and many more may' be discovered because albumin has a rate of molecular evolution three times that of hemoglobin (3) . Yet, up to 1978 some 85 different point mutations (single amino acid exchanges) had been established for'abnormal human hemoglobins (4) compared to only 1 for a variant albumin (5) . This disparity reflects two factors: (i) Unlike abnormal hemoglobins, alloalbumins are not associated with disease or a significant effect on physiological function, and most' are very rare (6) . (ii) The albumin molecule consists of a single polypeptide chain with 585 amino acids and 17 disulfide bridges, a circumstance that magnifies the difficulty of structural determination of a single substitution (7, 8) . However, investigation of human albumin variants has 'recently been stimulated by the advent of improved methods for structural study of proteins, by interest in protein genetics and 'evolution, and by knowledge ofthe complete protein (8) and genomic (9) sequence ofalbumin. As summarized by Takahashi et al. (10) (14, 15) .
The strategy we used for structural study of these alloalbumins consists of CNBr cleavage of the purified alkylated albumin followed by isoelectric focusing to identify the CNBr fragment in which the substitution occurs. The variant CNBr fragment is purified by HPLC and digested with trypsin or V8 protease. A peptide map of the digest is made by HPLC, and the variant peptide is purified and its amino acid composition and sequence are determined. An automated tandem HPLC system for tryptic peptide mapping (16) 
MATERIALS AND METHODS
Sera. A fresh specimen of lyophilized serum (5 ml) from an individual with the albumin Vancouver trait was provided by J. Frohlich (Vancouver, Canada). Lyophilized serum (2'ml) from the index case of albumin Birmingham was provided by R. Jefferis (Birmingham, U.K.). In both instances inheritance had been proved, the donor was heterozygous, and the variant had previously been described (12, 13) . By use of §Present address: Corporate Research and Development Laboratory, Toa Nenryo Kogyo K. K., Iruma-gun, Saitama-ken, Japan 354.
1To whom reprint requests should be addressed. cellulose acetate Microzone electrophoresis at pH 8.6 (Beckman) we compared these sera to reference sera containing alloalbumins for which we had determined the substitution. The same scheme was used for purification and characterization of the albumin in both cases.
Structural study of albumin Adana had been undertaken earlier by Franklin et al. (14) and again by Takahashi et al. (15) . In both studies the substitution had been localized to CNBr fragment CB6 (residues 447-548), but the site and nature of the amino acid exchange had not been determined because of the size of CB6 and the small sample available.
Purification and Characterization of Albumins. No attempt was made to separate the normal and variant albumins, and the total albumin was purified in two steps. In the first step for albumins Vancouver and Birmingham 1 ml of serum was subjected to ion-exchange HPLC on a Bio-Gel TSK DEAE-5PW column (7.5 x 75 mm) (Bio-Rad). The HPLC system has been described (16) . A gradient from 0o to 60% over 60 min with a flow rate of 1 ml/min was used from buffer A (0.01 M NH4HCO3) to buffer B (1.00 M NH4HCO3). The second step was gel filtration chromatography with a Toyo Soda TSK G4000SW column (7.5 x 600 mm) (Altex, Berkeley, CA) and isocratic elution with 0.1 M NH4HCO3 at a flow rate of 0.5 ml/min. Albumin Adana was purified by a similar procedure (16) . The purified albumin was characterized by cellulose acetate Microzone electrophoresis at pH 8.6 (Beckman model R101) and then was reduced and carboxymethylated and cleaved with CNBr as described (17) . As a reference standard for normal (common) albumin (albumin A) we used a commercial albumin from pooled human plasma (lot 102578, Calbiochem-Behring). This was carried through all the procedures applied to the albumins prepared from the heterozygous sera.
Screening and Purification of CNBr Fragments. Analytical isoelectric focusing of the CNBr fragments (10, 17) localized the substitution in all three variant albumins to CB6, a polypeptide containing 102 amino acid residues (positions 447-548). To purify CB6, the CNBr fragments were separated preparatively by reversed-phase HPLC on a Vydac C18 column (4.6 x 250 mm) (The Nest Group, Southboro, MA).
HPLC Peptide Profiles and Identification of Variant Peptide. In the first experiments the purified CB6 was digested with trypsin (16) . A tryptic peptide profile map was made by reversed-phase HPLC on a Vydac C18 column. Tryptic peptides of human albumin are given the prefix T and are numbered consecutively in their order in the sequence (16) .
After the analyses of the tryptic peptides indicated that the substitution was probably 501 Glu -+ Lys and thus at the N terminus of T67, we undertook to confirm this by preparing peptides of CB6 from albumins A and Vancouver with Staphylococcus aureus V8 protease (Miles). This digestion was at 37°C for 4 hr under conditions in which this enzyme is rather specific for glutamic residues and was predicted to yield a single confirmatory overlapping peptide (enzymeto-substrate, 1:20, wt/wt) (pH 7.8, 0.1 M NH4HCO3/5 mM EDTA). The peptide profile of the V8 protease digest was mapped by reversed-phase HPLC on a Vydac C18 column. The V8 peptides are given the prefix S and are numbered consecutively in their order in the sequence of human albumin. Under the conditions used the V8 protease produces a single peptide from albumin A (S50-51, residues 4%-505); a single peptide (S50-51*, residues 4%-505) is also obtained from albumin Vancouver, but it has the substitution 501 Glu -* Lys. (5, 10, 11) and also to proalbumins of the Christchurch type (-1 Arg -> Gln) (18) (Fig. 1) . However, the mobility of the Vancouver and Birmingham albumins was not affected by limited incubation with trypsin, and thus they did not appear to be proalbumins (Fig. 1) . Furthermore, isoelectric focusing of the CNBr fragments of all three alloalbumins indicated that the amino acid substitution was localized to CB6 (see figure 1 of ref. 15 criteria (12) . Furthermore, we studied the three variants at different times while working on many others. In fact, we had an inventory of more than 100 bisalbuminemic sera. Also, CB6 is a large polypeptide (102 residues) that has many potential sites of substitution, and no substitution in CB6 for a slow type of alloalbumin had yet been reported. Albumin Vancouver. To obtain the best separation of any particular one of the seven CNBr fragments of human albumin, the conditions for purification on a preparative scale must sometimes be modified. For some alloalbumins the variant CNBr fragment (e.g., CB4-C in albumin Cooperstown) separates well from the normal (CB4-A) (17) ; in other instances the variant CNBr fragment may overlap with a different normal CNBr fragment. In the case of albumin Vancouver the normal and variant CB6 fragments overlapped, but they separated adequately from the broad overlapping peaks of CB3, CB1, and CB5 (Fig. 3) .
The tryptic digest of this CB6 peak gave an HPLC profile in which the normal T67 peptide was reduced in relative amount and was adjacent to a new peptide peak (Fig. 4) . The latter was designated T67* after amino acid analysis showed an apparent substitution of one glutamic residue by a lysine. From the stoichiometry it appeared that the substitution could have occurred at either Glu-501 or Glu-518 in the 19-residue T67 peptide. If the exchange was at Glu-518, it might be difficult to complete the sequence analysis to the end of the peptide. Yet, if the exchange was at Glu-501, proof by sequence analysis would be easy but an overlap into the preceding sequence would not be established. Thus, we elected to purify a second preparation of CB6 and make a V8 protease digest to guide the strategy for sequence analysis of the tryptic peptide T67*.
The HPLC profile of the V8 protease digest of CB6 from albumin Vancouver (Fig. 5) showed the presence of a new peptide, designated S50-S51*, which was absent from the profile of CB6 from albumin A. There was a concurrent decrease in the peak labeled S50-51. Amino acid analysis was done for all the V8 protease peptides from albumin A and one of the alloalbumins. This showed that the two small potential V8 peptides, S50 and S51, which are adjacent in the sequence of albumin A, were linked as a single peptide despite the presence of a potential V8 protease-susceptible site at Glu-501. The amino acid composition and sequence analysis of S50-51* indicated it was a peptide composed of S50 and S51 with a Glu --Lys substitution at Glu-501 (Fig. 6) . Automated sequence analysis of the T67* tryptic peptide described above confirmed the 501 Glu --Lys exchange.
Albumin Bfrminglam. Preceding work (12) as well as our own studies described above had shown that this alloalbumin had many characteristics similar to those of albumin Vancouver. In particular, both had a slow 2 + mobility, and we had localized the substitution to CB6 in both cases. Thus (Fig. 4) except that the gradient was from 0%/ to 50% buffer B for 100 min. S50-51* denotes the variant peptide containing the amino acid substitution, and S50-51 is the normal peptide.
Birmingham serum. The chromatogram in reversed-phase HPLC of this digest was essentially identical to that shown in Fig. 3 for the CNBr digest of albumin Vancouver. A tryptic digest of CB6 Birmingham was prepared and submitted to HPLC exactly as for CB6 Vancouver. The HPLC profiles of the tryptic peptides of CB6 from the two alloalbumins were nearly identical. Both showed the appearance of the variant peptide T67*. Automated sequence analysis of T67* from CB6 of albumin Birmingham established the substitution 501
Glu --Lys (Fig. 6) . We had insufficient albumin Birmingham to confirm the substitution by making an independent V8 protease digest of this alloalbumin.
Albumin Adana. The serum specimen (C180458) had been collected in 1979 from a single patient in a hospital in Adana, Turkey. We had received the last remaining sample of the Adana serum (<1 ml) from B. Blumberg (Philadelphia) prior to receipt of the Vancouver and Birmingham specimens. In previous work (15, 16) we had confirmed the report of Franklin et al. (14) that CB6 was the site of substitution in this alloalbumin, but we had not identified the amino acid exchange. In our earlier study the total albumin from the Adana serum was purified and alkylated and was divided into two aliquots. One aliquot of the purified albumin from the Adana serum was digested with trypsin and was chromatographed by the automated tandem HPLC method (16) . Many peptide peaks had been identified by amino acid analysis, especially those from CB6, but no clue to the site of substitution in the Adana albumin was obtained. However, all the peptides were stored for future study.
In the present work a review was made of our previous amino acid analyses of the stored peptides from the tandem HPLC map, especially those that had a retention time about that predicted for T67 and T67*. A small peptide peak was identified that had a stoichiometry close to that expected for T67*. The sample was submitted to automated sequence analysis. An unambiguous sequence for 19 residues was obtained, which was identical to that of T67* given in Fig. 6 . This established the substitution 501 Glu -* Lys in albumin Adana. The second aliquot of the Adana albumin was digested with CNBr. The digest was analyzed by isoelectric focusing, which again confirmed that the substitution was in CB6. The CB6 fragment was purified by HPLC and digested (12) . However, the fresh specimen we studied had a ratio close to 1:1, which is similar to that reported for most bisalbuminemic sera (6) (12) . The maternal parents had migrated to Fiji from northern India (Lucknow). The paternal greatgrandparents had migrated to Fiji from an unknown part of India but spoke Urdu, which is the official language of Pakistan and is widely used in India. Albumin Birmingham was present in an Indian family from the Jullander district of the Punjab (13) . No family data are available for the single individual with albumin Adana. However, this city in southeastern Turkey is on the historic trade routes from the Indian subcontinent. Moreover, Kaur et al. (19) concluded that albumins Kashmir and Adana were identical within the limits of resolution of the methods they used, including similarity in the electrophoretic mobilities of CB6 from both albumins.
Despite the difference in dye binding of albumins Birmingham and Kashmir, it is likely that they are identical variants because they have the same electrophoretic mobility in six different media. Also, Kashmir and the Punjab are neighboring regions of northern India. Schell and Blumberg (1) have summarized a number of examples of albumin variants similar to Kashmir that have been found in Indian populations. They concluded that "albumin Kashmir is restricted to families of Indo-Dravidian descent, but it occurs more often than any of the other restricted variants." Indeed, albumins Kashmir and Afghanistan also appear to be identical on the basis of mobility in a series of systems (2) . Unfortunately, the civil unrest in this whole region has prevented willing colleagues from providing us with samples to test our hypothesis. Furthermore, this makes it difficult to assign a precedent name for the variant, as is the custom when several are shown to be identical (1) . The precedent name is probably albumin Kashmir. However, we propose that for the present this alloalbumin type be designated "albumin 501 Glu -+ Lys (Birmingham, Vancouver, Adana)." It should be recognized, however, that our results do not exclude the future finding of the same substitution in individuals who do not have north Indian ancestry.
